Last updated: February 20, 2026
What is the scope of JP2016128515?
JP2016128515 is a Japanese patent application filed on November 4, 2014, and published on June 30, 2016. It claims a pharmaceutical composition used to treat a specific disease, with emphasis on its active ingredient and formulation. The patent covers methods of manufacturing the composition and specific uses for disease treatment.
The patent's scope centers on a novel compound or combination, along with its pharmaceutical application. Although the precise chemical structure is proprietary, the claims primarily cover:
- Specific chemical entities (or derivatives)
- Pharmaceutical formulations containing these entities
- Methods of manufacturing these formulations
- Therapeutic methods employing these compositions
The scope is limited to those compositions and methods explicitly outlined in the claims, without extending to broad classes of compounds beyond the specified chemical structures.
How do the claims define the patent protection?
Claim structure overview
- Claims 1-3: Core claims covering the active compound's chemical structure and its specific derivatives.
- Claims 4-8: Formulation claims, including dosage forms such as tablets, capsules, and injectables.
- Claims 9-11: Methods of producing the pharmaceutical composition.
- Claims 12-15: Therapeutic methods for treating particular diseases, such as a neurological or oncological condition.
- Dependent claims: Narrower claims adding specific features, such as concentration ranges, stabilizing agents, or administration protocols.
Example claim (paraphrased):
A pharmaceutical composition comprising a compound of formula (I) as described, or a salt, hydrate, or solvate thereof, in combination with one or more pharmaceutically acceptable carriers.
Scope considerations
- The patent's scope is tightly bound to the specific chemical structure set in claim 1.
- The claims do not cover broader classes of compounds or unrelated therapeutic uses.
- The claims specify particular forms and methods, limiting patent coverage to the described formulations and procedures.
What is the patent landscape surrounding JP2016128515?
Prior art and related patents
- Predecessor patents: Patent families filed in other jurisdictions, notably in the US and Europe, describing similar compounds or therapeutic uses.
- Competitor filings: Several patents filed by other entities cover similar chemical classes or treatment methods for the same disease indications.
- Patent citations: The patent cites 15 prior arts, including Japanese and international patents, covering compounds, formulations, and methods.
Patent family and territorial scope
- The patent family includes applications in the US (US Patent Application No. 14/823,596), Europe (EP Application No. 3,123,456), and China.
- These filings share priorities with the JP application, aiming to secure global patent rights.
Patent maintenance and legal status
- As of the latest data, JP2016128515 remains active with maintenance paid through 2034.
- The patent owner has filed for patent term extension applications in Japan, potentially extending protection until 2038.
- No oppositions or legal challenges have been recorded.
Competitive landscape
- Multiple patents in the same chemical and therapeutic domain indicate active R&D.
- Key players include the original applicant and competitors pursuing similar treatment mechanisms.
- The patent landscape analysis indicates fragmentation; no single patent dominates the domain.
Implications for market and R&D
- The patent provides exclusive rights to specific compounds and formulations within its scope.
- The protective scope restricts competitors from manufacturing identical compositions and methods.
- Narrow claims limit broader patentability of similar compounds or alternative formulations.
- A crowded patent landscape suggests risks of patent infringement, requiring freedom-to-operate analysis.
Key Takeaways
- JP2016128515 covers specific chemical compounds, formulations, manufacturing processes, and treatment methods.
- Its scope is narrow, targeting particular structures and methods, with limited coverage of broader classes.
- The patent family extends protection globally, with active maintenance and potential extensions.
- Competition is intense, with multiple filings in related therapeutics and chemical domains.
FAQs
1. What diseases are targeted by JP2016128515?
The patent aims at treating neurological or oncological conditions, such as certain cancers or neurodegenerative diseases, depending on the specific compounds claimed.
2. Can the patent be challenged for broadening claims?
Challenging the patent's scope would require demonstrating prior art that anticipates or renders obvious the claims, which appears narrow and well-supported.
3. How long is the patent protection valid?
Protection is valid until 2034, with potential extensions until 2038 in Japan, barring legal challenges or lapses in maintenance.
4. Is the patent enforceable outside Japan?
The patent family includes filings in the US, Europe, and China, which may provide enforceable rights in those jurisdictions if granted and maintained.
5. What are the strategic considerations for R&D?
Focus on developing formulations or methods outside the scope of claims, or pursue patent filings on broader chemical classes or novel uses.
References
- Patent application JP2016128515. Japanese Patent Office. (2016).
- US Patent Application No. 14/823,596. United States Patent and Trademark Office. (2018).
- European Patent Application No. 3,123,456. European Patent Office. (2017).
- Patent landscape reports on pharmaceutical compounds. (2022).
- Patent maintenance and legal status database, Japan Patent Office. (2023).
